![]() |
![]() |
||
|
|
|||
|
|
|||
![]() |
![]() |
![]() |
![]() |
|
[Meet Our Trainees : Current] |
[Meet Our Trainees : Previous] |
[Meet Our Graduates] [Underrepresented Racial Ethnic Groups] | [Plan For Responsible Conduct of Research] |
Acceptance CriteriaPredoctoral applicants are evaluated on the basis of:
The postdoctoral fellows must also have proven academic accomplishments and hold the degrees of PhD or MD There are two postdoctoral programs. One is for those who have a PhD in epidemiology, biostatistics, molecular biology, molecular toxicology or genetics. For the PhD postdoctoral fellowship the individual will have had previous training in one programmatic area, e.g., epidemiology, and seeking research mentorship in another area, e.g. molecular genetics or vice versa. The PhD postdoctoral fellow will likely need a few courses to round their knowledge base but will spend at least 80% undertaking research. The postdoctoral physician applicant should have completed three years of their pediatric residency and have a strong interest in doing epidemiological or clinical studies using molecular skills and available cutting edge technology. Students with undergraduate degrees in molecular biology, molecular genetics or related fields are optimum candidates for predoctoral study. The Division of Epidemiology and Biostatistics (DEB) in the Department of Environmental Health (DEH) has had over 60 applicants per year. There are two excellent programs that will augment our predoctoral recruitment pool:
|
Meet our TraineesCurrently Funded
He completed his wet lab rotation under Dr. Anil Menon PhD. The research assistance covered methylation of the CpG islands and, as a consequence, deactivation of the leptin gene. The leptin gene product is associated with satiety. Lab protocols learned include DNA extraction from tissue/gels, restriction enzyme digests, agarose gel electrophoresis, spectrophotometry, PCR amplification, bisulfite treatment, ligation of and transformation with plasmids, clonal culturing, and preparations before sequencing. Mr. Klyza now conducts multivariate analysis of the bench laboratory data. S. Paranthaman, Ph.D, in Dr. Menon’s laboratory, is the mentor that obtains the raw data and is in charge of the project. Mr. Klyza and Dr. Paranthaman are collaborating to publish literature on the subject of epigenetics. In this year, Mr. Klyza also plans on an epigenetic analysis of the Framingham datasets, submitting his qualifying exam proposals, and completing the few remaining courses.
Postdoctoral physician fellows
Maninder Kalra M.D.: Dr. Kalra is a MD with previous training in Pediatrics, Pediatric Pulmonary Medicine and Sleep Medicine. He graduated from the MS Epidemiology program at University of Cincinnati in 2002. Dr. Ralph Buncher, Dr. Grace Lemasters and Dr. Raouf Amin have been his research advisors throughout his graduate studies and pulmonary fellowship. Drs Lemasters and Amin have continued in that role since Dr. Kalra was appointed faculty at University of Cincinnati. Dr Kalra’s primary research has been in determining factors that explain susceptibility to OSA in children. He has 9 articles as first/senior author articles and 3 co-authored articles that have been accepted or published in peer reviewed journals. He was accepted into the PhD Epidemiology program in 2005. He will complete all laboratory and coursework requirements in Winter, 2007. Dr. Kalra is interested in pursuing genetic risk factors for OSA in children with emphasis on gene-environment interactions for his PhD thesis. He seeks to accomplish this under the strong mentorship of Drs. LeMasters and Dr.Chakraborty.
Dr Stadler’s M.S. thesis research focused on the “Seroprevalance and Risk Factor Analysis of Cytomegalovirus (CMV) Infections In Adolescent Females” (DMID 04-039) the first of a three staged study entitled “A randomized, double-blind, placebo-controlled, Phase II Study to Assess the Safety and Efficacy of the Cytomegalovirus gB/MF59 Vaccine in Preventing Systemic Cytomegalovirus Infections in Healthy Adolescent Females (DMID 04-039)”, a multi-center seroepidemiology and vaccine trial of the leading vaccine candidate. A similar study in adolescent males “Seroprevalence and Risk Factor Analysis of Cytomegalovirus (CMV) Infections In Adolescent Males” (DMID 05-0126) is ongoing as well. Both studies are sponsored through Cincinnati Children’s Vaccine Trial Evaluation Unit (VTEU) with Vanderbilt University, and the University of Texas Medical Branch at Galveston and consist of three separate parts: a Seroprevalence study, Prospective Risk Factor Analysis (coupled with a vaccine trial), and a Prospective Viral Load Analysis. Participants will complete a comprehensive questionnaire of potential risk factors regarding: demographics, household contacts, environmental exposures, and sexual practices that will be analyzed with regard to CMV serostatus. The study aims are: to determine the seroprevalence of CMV infections and risk factors associated with prior infection, to prospectively determine the incidence of CMV and the risk factors of acquisition, and to determine the magnitude and duration of the CMV virus in blood, urine, and saliva (in those who become infected during the study). These studies will allow us to better understand the transmission of CMV, identify women of childbearing age likely to become infected, design prevention, counseling, and education strategies, and adequately power a vaccine trial including adolescent males. Dr Stadler is pursuing a Ph.D. in Epidemiology with this research serving as her dissertation topic.
Postdoctoral PhD or MD Candidates
Aim #1: To examine the role of mutations in Ctnnb1 in normal testicular development and spermatogenesis. Descriptive studies have suggested an important function for Beta-catenin in regulating normal mammalian spermatogenesis as well as a possible role in the development of testicular cancer. This study will use mouse models of Ctnnb1 gain- and loss-of-function mutations in the somatic and germ cells of the testis to empirically determine the function of Beta-catenin in maintaining male reproductive capacity. Aim #2: To examine the downstream effectors through which Beta-catenin exerts its function in the testis. Our preliminary studies have demonstrated a role for Beta-catenin function, acting through the somatic Sertoli cells, in the regulation of germ cell development in the testis. To determine how Beta-catenin accomplishes this function, we will identify its downstream transcriptional targets within the testis and evaluate the function of validated targets in establishing and/or maintaining testicular homeostasis. |
Meet our TraineesPreviously Funded
|
Meet our Graduates
Dr. Woo’s research focuses on genetic and environmental factors that predispose children and adolescents to obesity and its metabolic complications, such as insulin resistance and dyslipidemia. Her dissertation research explored the particular role of the adipocyte protein adiponectin as a biomarker for protection against these poor metabolic outcomes, and the role of genetic polymorphisms in the adiponectin gene, ACDC. Results from her dissertation research are published in such journals as the Journal of Clinical Endocrinology and Metabolism, Diabetes and Obesity Research. Since the completion of her dissertation, Dr. Woo has extended her research to include infancy as another critical period in the development of predisposition to obesity and its complications. To pursue this research, she received pilot funding from the University of Cincinnati Center for Environmental Genetics to examine the genetic susceptibility to the environmental contaminant bisphenol A (BPA) and its metabolite bisphenol A diglycidyl ether (BADGE) with respect to adiponectin and insulin resistance during pregnancy. She has also submitted a grant to the NIH to study the role of adiponectin in human milk. Dr. Woo’s participation in the MECEH training program was instrumental in her current research path. Practical laboratory training in genotyping prepared her to undertake the significant genotyping required for her dissertation research. In addition, her work centers on the use of molecular genetics and the use of molecular biomarkers in epidemiologic research, which would not have been possible without the coursework undertaken through the MECEH training program.
Michelle Stevenson, M.D.: Dr. Stevenson has completed all required credits towards her MS in Epidemiology. She is a pediatric emergency medicine fellow who developed her research interests in acute asthma with Dr. Hershey. She has developed a project entitled “IL-4 and IL-13 Signaling Pathways: Allelic Variants, Biomarkers, and Correlates to Functional Outcome in Pediatric Asthma.” This work was presented at two national meetings. Through this project she has obtained significant “wet” lab experience in Dr. Hershey’s lab in learning flow cytometry and PCR and did a dry lab experience with Dr. Shukla in the Center for Biostatistical Services. Dr. Stevenson has submitted for a K08 award in June, 2004 as she transitions into her academic career. Dr. Stevenson received a Fellow-In-Training Travel Scholarship to the American Academy of Allergy, Asthma, and Immunology Annual Meeting in March, 2004. She has three publications and one in progress and two presentations at national conferences. Steve Sutton, M.D.: Dr. Sutton is a second year Fellow and will finish the program June 2005. His fellowship research has centered on egg food allergy. He presented preliminary data at the annual meeting of the American College of Asthma, Allergy and Immunology in November, 2002. He also has an interest in immunology and is a co-investigator of an ongoing study concerning the effects of anti-IL-5 on individuals with hypereosinophilic diseases. Another project is in Dr. Gurjit K. Hershey’s laboratory looking at gene-environment interactions and the development of asthma. He is currently helping design the study and will be working on collecting patient genetic and environmental data as well as analyzing the data. Dr. Sutton will graduate summer 2005. His primary research advisor is Drs. LeMasters, Hershey and, Assa’ad the latter two in the division of Allergy and Immunology. He has 3 publications and 1 book chapter and has submitted for a K08 award.
Stavra Xanthakos, M.D: Dr. Stavra Xanthakos is in her third year in the fellowship program and has completed all courses and will have completed her labs by spring 2005. She will graduate summer 2005. Her primary research advisor is Dr. Daniels. Her area of research will be directed toward pediatric gastroenterology. Her master’s thesis research is the prevalence and determinants of nonalcoholic fatty liver disease in young adult women. Her central hypothesis is that high visceral adiposity, high body mass index (BMI), insulin resistance syndrome, high dietary intake of fat and sugar and lower socioeconomic status in childhood enrollment of study subjects and data analysis is in progress. (Note: Dr.Xanthakos is being funded on the MECEH years 01 and 03 but for the year effective September 2003 she was funded from another NRSA training grant fund (PI Dr. Mitch Cohen in Pediatrics at the CHMC). |
Underrepresented Racial Ethnic GroupsHistory and Achievements
To address the current need for increased applications from underrepresented domestic students, the Office of Research & Graduate Education, responsible for centralized support of recruitment of graduate students for the College of Medicine, is targeting historically black colleges and universities. In 2001, the Office of Research & Graduate Education sent representatives to present seminars at historically black colleges, including Tennessee State University in Nashville, Spelman and Morehouse Colleges in Atlanta, and Wilberforce and Central State Universities in Ohio. Among other activities described, recruiters and minority graduate students from the College visit campuses with larger minority student bodies and good science programs to present information about our predoctoral programs in biomedical sciences. Several plans have been laid out to increase minority enrollment. We are establishing a formal partnership with minority colleges. Two potential colleges with minority students have been identified to serve as partners to develop a partnership or pipeline between the programs. One is the aforementioned Xavier-Tulane pipeline program with the support of Dr. John McLachlan at Tulane University. Dr. Deka plans outreach activities specifically to colleagues at Howard University. We are also exploring opportunities to link with a program in our tri-state area and contacts are underway. The University sponsors a Minority Graduate and Professional Visitation Program that attracts about 100 students from more than 20 historically Black colleges and universities. The students spend 2-1/2 days on campus visiting graduate departments and programs in which they are interested, including those in the college of medicine, and attending programs and social events, including a banquet, especially designed for this occasion. Visiting students have ample time to interact with faculty and students to learn more about programs of interest. Prospective students are provided with information regarding admission policies and financial aid, and subsequent follow-up is done on a departmental basis, usually by telephone contact. The College of Medicine also actively participates in the Environmental Health Career Opportunities (EHCO) Program and Albert Yates’ Fellows and Scholars Program. The EHCO Program is designed to involve undergraduate and/or professional school students who belong to ethnic groups currently underrepresented in biomedical science professions in contemporary biomedical research during the summer months. The Program emphasizes comprehensive research, educational and motivational experiences that focus on biomedical research and education careers related to environmental health and associated sciences. The ECHO Program expects to support four participants each year. The Program provides use of the University of Cincinnati Medical Center, University Hospital, Children’s Hospital Medical Center and Research Foundation, and affiliated biomedical research facilities and core resources for summer research, education and training. These students often matriculate as predoctoral students in one of the environmental health sciences.
Department of Environmental Health The Department of Environmental Health also are represented at the NIGMS Minority Programs Symposium by two University of Cincinnati representatives, one faculty member and one graduate student, and as indicated earlier, we participate in the graduate Minority Fellows and Scholars Program, which funded 50 students throughout the University last year.
Epidemiology and Biostatistics |
Plan For Responsible Conduct of Research
Grievances and Misconduct Procedure
Ethics and Honesty in Research |